Division of Urology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada.
Platform Biological Sciences, Sunnybrook Research Institute, University of Toronto, Toronto, ON, Canada.
Anticancer Res. 2020 Dec;40(12):6649-6663. doi: 10.21873/anticanres.14689. Epub 2020 Dec 7.
BACKGROUND/AIM: We previously identified a panel of five miRNAs (including miR-139) associated with biochemical recurrence and metastasis in prostate cancer patients.
We examined miR-139 transfected PC3, DU145 and LNCaP cells by morphology as well as by cell-based assays, confocal microscopy and immunoblotting.
We found that treatment of prostate cancer cells with miR-139 resulted in phenotypic changes characteristic of autophagic cells. MiR-139 increased the autophagy-related conversion of the microtubule-associated protein light chain 3 (LC3-I to LC3-II) that was specifically inhibited by the miR-139 antagomir. The upregulation of LC3 II was further confirmed by confocal microscopy. miR-139 regulated activation of both mTOR and Beclin1 the two important autophagy-related molecules. We found that upon miR-139 treatment, the cargo adaptor protein p62 which is degraded during autophagy, accumulates.
These results suggest that miR-139 is inducing autophagic flux blockade leading to apoptosis in prostate cancer cells through the mTOR and Beclin-1 proteins.
背景/目的:我们之前确定了一组与前列腺癌患者生化复发和转移相关的五个 miRNAs(包括 miR-139)。
我们通过形态学以及细胞基础检测、共聚焦显微镜和免疫印迹法检查了转染 miR-139 的 PC3、DU145 和 LNCaP 细胞。
我们发现,miR-139 处理前列腺癌细胞导致具有自噬细胞特征的表型变化。miR-139 增加了微管相关蛋白轻链 3(LC3-I 向 LC3-II)的自噬相关转化,该转化被 miR-139 反义寡核苷酸特异性抑制。共聚焦显微镜进一步证实了 LC3 II 的上调。miR-139 调节了两个重要的自噬相关分子 mTOR 和 Beclin1 的激活。我们发现,在用 miR-139 处理后,货物衔接蛋白 p62 在自噬过程中降解,其积累。
这些结果表明,miR-139 通过 mTOR 和 Beclin-1 蛋白诱导前列腺癌细胞中自噬通量阻断,导致细胞凋亡。